Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Crucell, Wyeth Enter Vaccine Development Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Crucell, Wyeth Enter Vaccine Development Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Crucell N.V. has entered into an exclusive vaccine development agreement with Wyeth Pharmaceuticals. Under the terms of the agreement, Crucell will be responsible for the development and manufacture of certain components of a vaccine for use in Wyeth clinical studies. The development activities will take place in Crucell’s vaccine manufacturing facilities in Bern, Switzerland. Wyeth will be responsible for the clinical development of the vaccine. Financial details were not disclosed.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters